Previous Article | Next Article ![]()
Infection and Immunity, June 2001, p. 3678-3684, Vol. 69, No. 6
Department of Otolaryngology, College of
Medicine and Public Health, The Ohio State University, Columbus, Ohio
Received 3 January 2001/Returned for modification 31 January
2001/Accepted 2 March 2001
To define the role of nontypeable Haemophilus
influenzae (NTHI) lipooligosaccharide (LOS) in the induction of
proinflammatory cytokine gene expression during otitis media, we
compared the abilities of formalin-killed NTHI strain 2019 and its LOS
htrB and rfaD mutants to stimulate human
middle ear epithelial (HMEE) cell cytokine and chemokine gene
expression and production in vitro. Strain DK-1, an rfaD
gene mutant, expresses a truncated LOS consisting of only three
deoxy-D-manno-octulosonic acid residues, a
single heptose, and lipid A. Strain B29, an isogenic
htrB mutant, possesses an altered oligosaccharide core
and an altered lipid A. HMEE cells were incubated with formalin-killed
NTHI 2019, B29, or DK-1. The supernatants and the cells were collected
at 2, 4, 8, and 24 h after stimulation. Expression of genes for
the cytokines tumor necrosis factor alpha (TNF- Considerable evidence
indicates that endotoxin or its subcomponent lipopolysaccharide (LPS)
or lipooligosaccharide (LOS), each an integral component of the outer
membrane of gram-negative bacteria, is refractile and present in a
large percentage of middle ear effusions from children with otitis
media (OM) (10, 14). Endotoxin is a potent stimulant of
proinflammatory reactions of the host's innate immune response
(22). The inflammatory cytokines are thought to be of
central importance in the pathogenesis and regulation of proliferation,
chemotaxis, and activation of inflammatory cells during the course of
middle ear infections (21, 29). A previous report from our
laboratory indicates that there is a significant correlation between
endotoxin, tumor necrosis factor alpha (TNF- Major advances have also been made recently in identifying the
molecular mechanisms underlying LPS or endotoxin recognition and
signaling for LPS-induced cell activation. It is believed that
membrane-bound CD14 (mCD14), a glycosyl phosphatidylinositol-anchored protein expressed on myeloid cells, binds to LPS and initiates its
signaling (33). Toll-like receptors (TLRs) have been
identified as the signaling molecules and may act as transmembrane
coreceptors with CD14 in LPS activation of different cell populations
(15). The potential role of NTHI LOS in the activation of
HMEE cells via these pathways has also not been explored.
It is now possible to define the role of NTHI LOS in the pathogenesis
of OM by using mutants with various LOS gene disruptions as tools. A
recent study from our laboratory indicates that disruption of the NTHI
htrB and rfaD LOS genes does not impact the
ability of NTHI to colonize the nasopharynx; however, it induces marked differences in the abilities of the two LOS mutants to induce OM and
survive in the middle ear (9). In this study, the relative contributions of disruption of NTHI htrB and rfaD
LOS genes to proinflammatory cytokine gene expression by HMEE cells
were quantitated by a novel, highly accurate, and reproducible
real-time PCR amplification technique. Our data demonstrate that NTHI
LOS htrB gene products play an important role in the
induction of proinflammatory cytokine genes in cultured HMEE cells.
Bacteria.
The following NTHI strains were obtained from
Michael A. Apicella, University of Iowa College of Medicine, and were
used in this study. All have been previously described (17, 18,
25).
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3678-3684.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Expression of Cytokine and Chemokine Genes by Human
Middle Ear Epithelial Cells Induced by Formalin-Killed
Haemophilus influenzae or Its Lipooligosaccharide
htrB and rfaD Mutants
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
), interleukin l
(IL-1
), and IL-6 and for the chemokines macrophage inflammatory
protein 1
(MIP-1
), monocyte chemotactic peptide 1 (MCP-1), and
IL-8 was quantitated by real-time PCR. NTHI B29 did not significantly
stimulate any cytokine or chemokine mRNA expression in HMEE cells. In
striking contrast, NTHI 2019 induced up to 105-, 139-, and 187-fold
increases in HMEE cell expression of IL-1
, TNF-
, and MIP-1
,
respectively (P < 0.01 [2019 versus B29]). NTHI
2019 also induced upregulation of IL-8, IL-6, and MCP-1 mRNA expression
(by 26-, 44-, and 14-fold, respectively [P < 0.05 {2019 versus B29}]). The significant induction of cytokine genes
was confirmed by quantitating the secretion of cytokines in culture
supernatants with an enzyme-linked immunosorbent assay. There were no
significant differences in mRNA expression of IL-8, IL-6, and MCP-1
between the 2019- and DK-1-treated groups. The low levels of gene
transcripts observed after incubation of HMEE cells with B29 indicate
that products of the disrupted NTHI htrB LOS gene may
play a major role in induction of these particular inflammatory mediators.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
), and interleukin 1
(IL-1
) concentrations in middle ear effusions from children with OM
(35). Recent experimental studies, moreover, demonstrate
that formalin-killed nontypeable Haemophilus influenzae
(NTHI) stimulates the release of IL-1
, IL-6, IL-8, and TNF-
from
the middle ear mucosa in the guinea pig OM model (30). It
has been proposed that the initial interaction of endotoxin with middle
ear epithelium leads to the production and release of inflammatory
cytokines in the middle ear (2, 5, 8). This is followed by
recruitment of neutrophils, eruption of a cytokine-mediated
inflammatory cascade, and neutrophil activation, resulting in the
release of inflammatory molecules which participate directly in middle
ear inflammation (27, 37). To date, reports on the effects
of NTHI LOS on induction of cytokine gene expression by human cells
have focused primarily on stimulation of monocytes (34)
and bronchial and tracheal epithelial cells (7, 16, 24).
The effects of NTHI LOS on cytokine and chemokine gene expression by
cultured human middle ear epithelial (HMEE) cells have never been reported.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Preparation of formalin-killed NTHI strains. The use of whole, formalin-killed bacterial cells as a source of endotoxin was developed in our laboratory over 15 years ago and is widely used (26, 30). NTHI strains were grown on sBHI agar, with or without antibiotics as indicated above, overnight in a CO2 incubator at 37°C. The bacteria were harvested, washed in sterile phosphate-buffered saline, and killed by incubation with 0.3% formalin at room temperature for 24 h, as previously reported (26). Killed NTHI strains were washed three times in sterile phosphate-buffered saline and suspended in cell culture medium at a concentration of 2 × 107 CFU per milliliter for the experiment.
Cell culture.
Two primary cultures of HMEE cells were
established from middle ear biopsy specimens taken near the orifice of
the eustachian tube from a 19-year-old patient and a 34-year-old
patient undergoing acoustic neuroma surgery at The Ohio State
University Medical Center, Columbus, Ohio. The biopsy specimens were
minced and washed in ice-cold Hanks' balanced salt solution containing
10 U of penicillin/ml, 10 µg of streptomycin/ml, 500 ng of
amphotericin B (Fungizone)/ml, and 5% fetal bovine serum and were
subsequently digested with 0.01% trypsin-0.1 M EGTA for 10 min at
room temperature. The minced biopsy suspensions were then placed in a
25-cm2 Corning tissue culture flask and cultured
in modified minimal essential medium
(MEM
) (Gibco BRL,
Gaithersburg, Md.) buffered with 155 mg of NaHCO3
and 3.6 g of HEPES/liter supplemented with 5 mg of insulin/liter,
2 mg of transferrin/liter, 500 µg of hydrocortisone/liter, 25 ng of
epithelial growth factor/ml, 10 µg of streptomycin/ml, 5 U of
penicillin/ml, 10% fetal bovine serum, and 250 ng of amphotericin B/ml
at 37°C. All medium additives were from Collaborative Research (Boston, Mass.).
Characterization of HMEE cells. Anti-cytokeratin polypeptide 8, 18, and 19 antibody (Vector Laboratories, Burlingame, Calif.) probes were used to immunocytochemically characterize the cells. Monoclonal antivimentin (clone V9; Sigma-Aldrich, St. Louis, Mo.), which labels vimentin in fibroblast cells, was used to rule out fibroblast contamination.
mRNA expression of TLR2, TLR3, TLR4, and mCD14 genes was examined in cultured HMEE cells by means of reverse transcription (RT)-PCR. Total cellular RNA was extracted by using an RNeasy Mini Kit (Qiagen, Valencia, Calif.), and the first cDNAs were synthesized with the SuperScript preamplification system (Gibco BRL). The primers and PCR conditions for each amplified gene have been published previously (4, 38). The primers used for TLR2 were 5'-GCC AAA GTC TTG ATT GAT TGG-3' and 5'-TTG AAG TTC TCC AGC TCC TG-3'. The primers used for TLR3 were 5'-AAA TTG GGC AAG AAC TCA CAG-3' and 5'-GTG TTT CCA GAG CCG TGC TAA-3'. The primers used for TLR4 were 5'-TGG ATA CGT TTC CTT ATA TG-3' and 5'-GAA ATG GAG GCA CCC CTT C-3'. Expression of human mCD14 mRNA was assessed by RT-PCR with the primers 5'-GGT GCC GCT GTG TAG GAA AGA-3' and 5'-GGT CCT CGA GCG TCA GTT CCT-3'. The PCR products for each gene were confirmed by DNA sequencing, which was performed by the Neurobiotechnology Center of The Ohio State University.Stimulation of HMEE cells.
HMEE cells were seeded at a
concentration of 1.5 × 105 cells per
150-cm2 tissue flask (Costar Corp., Cambridge,
Mass.) in freshly supplemented MEM
and grown to approximately 80%
confluency. The cells were washed, and the medium was replaced with
serum-free MEM
containing 250 µg of bovine serum albumin/ml. The
cells were grown overnight and were 90% confluent by the next day. The
growth medium was replaced with fresh serum-free medium containing 250 µg of bovine serum albumin/ml. Cell cultures were incubated either
with formalin-killed NTHI parent strain 2019 or with formalin-killed
B29 or DK-1 LOS mutant cells (2 × 107
CFU/ml). This challenge dose has been used previously (7). The experiment included an unstimulated negative control flask and a
positive control flask incubated with TNF-
(20 ng/ml;
Sigma-Aldrich), as described for a previous study that used cytokines
in positive controls (7). Supernatants from HMEE cell
cultures were removed from each culture, and host cell total RNA was
isolated after 2, 4, 8, and 24 h of incubation at 37°C.
Quantitation of HMEE cell cytokine transcripts by real-time
PCR.
Real-time PCR is a novel method that allows for rapid,
accurate, and precise quantitation of gene transcripts (12,
13). Real-time PCR assays were performed, with modifications, as
part of this study to specifically quantitate human cytokine (TNF-
, IL-1
, and IL-6) and chemokine (monocyte chemotactic peptide 1 [MCP-1], macrophage inflammatory protein 1
[MIP-1
], and IL-8) transcripts. Total cellular RNA extraction and the first cDNA synthesis
were performed as described above. Each cDNA sample was then used as a
template for a PCR amplification mixture containing forward and reverse
primers (450 nM [each]), 6-carboxyfluorescein-labeled probe (125 nM)
for the target cytokines, forward and reverse primers for 18S rRNA (100 nM [each]), 2,7-dimethoxy-4,5-dichloro-6-carboxyfluorescein-labeled probe (100 nM) for 18S rRNA (internal control), and 2×
TaqMan Universal PCR Master Mix (Perkin-Elmer Applied
Biosystems, Foster City, Calif.). PCR amplifications for the target
cytokine and internal control 18S rRNA were performed in a single well
of a capped 96-well optical plate. Reaction mixtures were subjected to
the following amplification scheme: 1 cycle at 50°C for 2 min (AmpErase uracil-N-glycosylase deactivation) and 1 cycle at
95°C for 10 min (AmpliTaq Gold activation), followed by 40 cycles at 95°C for 15 s (denaturation) and 60°C for 1 min
(annealing and extension). Real-time PCR data were analyzed by using
Sequence Detection software, version 1.6, included with the 7700 Sequence Detector (Perkin-Elmer Applied Biosystems). Final quantitation was derived using the comparative CT
(threshold cycle) method (see below) and was reported as the fold
difference relative to a calibrator cDNA (negative control,
nonstimulated HMEE cells) prepared in parallel with the experimental
cDNAs. All calculations were performed with the Microsoft Excel
software program (Microsoft, Redmond, Wash.). The primers and probes
for TNF-
, IL-1
, IL-6, and MIP-1
used in this study are
commercially available and were obtained from Perkin-Elmer Applied
Biosystems. The primers and probes for IL-8 and MCP-1 were designed by
using Primer Express software, version 1.0 (Perkin-Elmer Applied
Biosystems). The primers for IL-8 were 5'-GCG CCA ACA CAG AAA TTA TTG
TAA-3' and 5'-TTA TGA ATT CTC AGC CCT CTT CAA-3', and the probe for
IL-8 was 5'-TTC TCC ACA ACC CTC TGC ACC CAG TT-3' (GenBank accession
no. M28130) (23). The primers for MCP-1 were 5'-TCG CTC
AGC CAG ATG CAA T-3' and 5'-CCA CAA TGG TCT TGA AGA TCA CA-3', and the
probe for MCP-1 was 5'-TCA CCA GCA GCA AGT GTC CCA AAG AA-3' (GenBank
accession no. M37719) (31). These primers and probes were
synthesized by Perkin-Elmer Applied Biosystems.
Comparative CT
method.
The comparative CT method has
been described previously (11). Briefly, the fractional
cycle at which reporter fluorescence generated by cleavage of the probe
passes a fixed threshold above baseline is defined as the threshold
cycle (CT). 18S rRNA was used as an
internal control to distinguish true target-negative results from PCR
inhibition and to normalize for differences in the amounts of total
nucleic acid added to a reaction mixture. Detection of multiple target
cDNAs in the sample tube was achieved by labeling probes with different
and distinguishable reporter dyes. For relative quantitation, values
are expressed relative to a reference sample, called the calibrator
(negative control in this study), and relative quantitation was
calculated by the comparative CT method.
First, the CT for the target amplicon and the CT for the internal control were
determined for each sample. Differences in the
CT for the target and the
CT for the internal control, called
CT, were calculated to normalize for
the differences in the amounts of total nucleic acid added to each
reaction mixture. Then, the
CT for each
experimental sample was subtracted from the
CT of the calibrator. This difference
is termed the 
CT. Finally, the
amount of target normalized to an internal control and relative to the
calibrator was calculated by the equation 2

CT.
Thus, all experimental results are expressed as fold differences relative to the calibrator.
ELISA.
Cell supernatants were centrifuged at 500 × g and frozen at
70°C. Cytokine and chemokine
concentrations in culture supernatants were measured by commercial
enzyme-linked immunosorbent assay (ELISA) kits (Quantikine; R&D
Systems, Minneapolis, Minn.), according to the manufacturer's instructions.
Statistical analysis. The arithmetic mean fold increase ± the standard error of the mean (SEM) of cytokine or chemokine mRNA expression over the corresponding value for resting cells, based on three replicates per experiment, was calculated. Statistical analyses were performed with Student's t test; a P value of <0.05 was used as the level of significance for all analyses.
| |
RESULTS |
|---|
|
|
|---|
Primary culture of HMEE cells.
A primary explant
culture from HMEE cells is shown in Fig.
1. These cells were serially passaged up
to 15 times. The growth kinetics of HMEE cells exhibited a
characteristic sigmoid curve. The cumulative population doubling level
(PDL) of these primary cells was 25.4 before termination of growth at
57 days in culture. The average PDL per passage of the primary culture
of HMEE cells was 2.1. Immunocytochemical staining positively
identified cytokeratins 8, 18, and 19 in both HMEE primary cell
cultures, with strong staining for cytokeratin 18 (Fig.
2); vimentin was not detected in these
cells (data not shown), indicating that they were of epithelial origin.
We successfully amplified mRNA of mCD14, TLR2, TLR3, and TLR4 from the
two primary cultures of HMEE cells (Fig. 3).
|
|
|
Kinetics of cytokine and chemokine production after NTHI
stimulation.
The cytokine and chemokine concentrations in the
supernatants of HMEE cells maintained with culture medium only (control
group) were used as measures of constitutive production by unstimulated HMEE cells. Under these conditions, low levels of IL-6, IL-8, and MCP-1
activities were detected in the supernatants (Fig.
4). However, no secreted IL-1
,
MIP-1
, or TNF-
was detected in culture supernatants from
unstimulated cells at any time during this experiment.
|
Cytokine and chemokine gene expression in HMEE cells after NTHI
stimulation.
In order to define the roles of the NTHI
htrB or rfaD gene products in the induction of
proinflammatory cytokine transcription in HMEE cells and to examine
whether the NTHI-stimulated secretion of cytokines and chemokines by
HMEE cells was due to release from internal stores or due to de novo
synthesis, gene expression was evaluated by real-time PCR analysis.
Stimulation of HMEE cells with TNF-
(20 ng/ml) (the positive
control) showed increases in peak mRNA responses with TNF-
(4,300-fold) and MIP-1
(1,164-fold) after 2 h of coincubation,
with IL-1
(199-fold) and IL-8 (62-fold) after 4 h of
coincubation, and with IL-6 (76-fold) and MCP-1 (28-fold) after 24 h of coincubation.
, IL-1
, and MIP-1
genes were strongly induced by NTHI 2019 (105- to 187-fold increases over control levels), while IL-8, MCP-1,
and IL-6 genes were intermediately induced by NTHI 2019 (14- to 44-fold
increases) (Fig. 5 and
6). Significant increases in TNF-
,
IL-1
, and MIP-1
mRNA expression were evident as soon as 2 to
4 h after stimulation of HMEE cells with formalin-killed NTHI
2019, and expression continued to increase even further for 6 h. A
peak value was evident at 8 h, with a decrease at 24 h. However, expression of cytokine and chemokine genes was either not
induced at all or induced at a reduced level by B29. In addition, DK-1
induced 65-, 39-, and 41-fold increases in MIP-1
, IL-1
, and
TNF-
mRNA expression, respectively, increases which were approximately three times lower than those induced by NTHI 2019. Moreover, at 8 h after stimulation, there were no significant differences between the levels of IL-8, MCP-1, and IL-6 mRNA expression in HMEE cells treated with NTHI 2019 and the corresponding levels in
cells treated with DK-1 (Fig. 5 and 6).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Previous data indicate that 77% of middle ear effusions from patients with OM exhibit bacterial cells by Gram staining; however, only 52% or less are culture positive (19). The use of formalin-killed NTHI was developed over 15 years ago to simulate this clinical window, i.e., when the acute inflammatory phase has resolved and bacterial pathogens have been killed by either antibiotics or host immune mechanisms, and it is a widely used method of inducing sterile OM (26).
In this study, IL-6, IL-8, and MCP-1 were secreted constitutively by
HMEE cells. Our results indicate that HMEE cell interactions with
intact, killed NTHI bacterial cells stimulate early mRNA expression of
the proinflammatory cytokines TNF-
, IL-1
, IL-6, IL-8, MCP-1, and
MIP-1
by 2 to 4 h after stimulation. This early gene expression
precedes an increased secretion of IL-6, IL-8, and MCP-1 within 24 h of stimulation. IL-1
, MIP-1
, and TNF-
mRNA transcripts were
detected, but their products (proteins) were not detectable in culture
supernatants. The reason for this is not entirely clear, but the most
apparent explanation is that the cultured cells have been
dedifferentiated and the secretory machinery required for excretion is
no longer present. There is no question that these particular
inflammatory mediators have been identified as being produced in vivo.
Recent reports, moreover, indicate that IL-1
transcription does not
always correlate with translation and that a nonsecreted form of
TNF-
is produced by normal human breast epithelial cells in vitro
(3, 7). TNF-
was not detected in cell supernatants
during the present study; however, it was detected by Western blotting
in nuclear extracts of HMEE cells after NTHI 2019 stimulation (data not
shown). This suggests that HMEE cells may produce a nonsecreted form of
TNF-
during the early phase of NTHI LOS stimulation in vitro. The
rapid induction and kinetics of HMEE cell cytokine and chemokine gene expression subsequent to exposure with killed NTHI suggest that the
middle ear epithelium might be the first site of proinflammatory cytokine production during the course of OM. The results from this
study are in line with several publications reporting the upregulation
of IL-1
, IL-6, and TNF-
expression during experimental induced OM
(21, 30). Moreover, our data correlate well with studies
showing induction of IL-6, IL-8, IL-1
, and MCP-1 from human tracheal
epithelial cells in response to stimulation with NTHI LOS
(7).
The present data demonstrate that HMEE cells exposed to the NTHI 2019 parent strain express significantly higher levels of mRNA and release
higher levels of both cytokines and chemokines than those exposed to
its LOS mutant B29. These results suggest that NTHI LOS htrB
gene products are responsible for the induction of proinflammatory
cytokine gene expression in HMEE cells after stimulation with killed
NTHI cells. The chemokine most strongly induced by NTHI 2019 is
MIP-1
, which belongs to the CC chemokine subfamily, is chemotactic
primarily for monocytes and T cells, and activates T cells and
macrophages (6). The cytokines most strongly induced by
NTHI 2019 were TNF-
and IL-1
. TNF-
contributes to the acute
phase of the inflammatory response, primes the immune system for rapid
activity (36), and promotes the release of other
cytokines. The DK-1 rfaD mutant, expressing a truncated oligosaccharide and lipid A, induced three times lower mRNA expression of IL-1
, MIP-1
, and TNF-
than did NTHI 2019, which suggests a
partial role for rfaD gene products in the induction of
these cytokines in HMEE cells.
NTHI 2019 and DK-1 moderately induced IL-6, IL-8, and MCP-1. IL-8 belongs to the CXC chemokine subfamily, is chemotactic primarily for neutrophils (and for T cells, NK cells, endothelial cells, basophils, and eosinophils), and stimulates neutrophil degranulation, adhesion, and microbicidal activity (32). IL-6 has been shown to be essentially protective in infection, which is linked to its capacity to induce the release of acute-phase protein (6). Slower kinetics of induction of MCP-1 are consistent with its newly discovered anti-inflammatory properties (39). MCP-1, in addition to its role in chemotaxis, also downregulates production of proinflammatory cytokines (39), which is beneficial at the later, rather than early, stages of the NTHI-induced inflammatory process. There were no significant differences between the mRNA expression and secretion of IL-6, IL-8, and MCP-1 in the NTHI 2019 group and those of the DK-1 group, suggesting that the products of rfaD do not play a significant role in induction of these cytokine genes by HMEE cells.
The NTHI htrB mutant did not significantly stimulate
cytokine or chemokine expression in HMEE cells, thus providing
additional direct evidence for the role of NTHI htrB
products in the induction of proinflammatory cytokines in HMEE cells.
It is noteworthy that the abilities of NTHI 2019 and each LOS mutant to
induce cytokine and chemokine gene expression are closely related to
their virulence in the chinchilla OM model in vivo (9).
These data corroborate earlier findings of Nichols et al., who
originally described the reduced ability of NTHI B29 to induce TNF-
production in vitro, that the host's TNF-
expression is attenuated
in response to NTHI htrB mutant strains (24).
Data from this study suggest that the middle ear epithelium itself
appears to play a key role in upregulation of the host immune defense
by recognizing and subsequently responding to invading pathogenic
threats by secretion of proinflammatory cytokines. Our results show for
the first time that mRNAs of mCD14, TLR2, TLR3, and TLR4 are expressed
in HMEE cells. Recent attention has focused on putative LPS receptors
found on the surfaces of cells, the relationship of these receptors to
LPS-induced signal transduction, and the role of each in development of
the proinflammatory response. LPS elicits several immediate
proinflammatory responses in peripheral blood leukocytes via several
recently described signaling pathways: CD14, TLRs, serine-threonine
kinases, and the NF-
B transcription factor (1, 20, 28).
Until recently, however, little was known about how the NTHI LOS signal
is transduced across the plasma membrane in HMEE cells. As the basic
understanding of NTHI LOS signal transduction grows, novel therapies
that can effectively improve the outcome of NTHI OM may arise.
In conclusion, the significant decline in gene transcript levels observed with the NTHI B29 mutant indicates that the product of the NTHI LOS htrB gene plays a major role in induction of these particular inflammatory mediators. The experiments described here contribute to our understanding of the role of various LOS gene disruptions in OM pathogenesis and may thus lead to new targets for future protection and intervention strategies.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported in part by grant 5 R01 DC00090-28, from the National Institute on Deafness and Other Communication Disorders, National Institutes of Health, to T.F.D.
We thank Kathy Holloway for manuscript preparation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Otolaryngology, The Ohio State University, Room 4331 UHC, 456 West 10th Ave., Columbus, OH 43210. Phone: (614) 293-8103. Fax: (614) 293-5506. E-mail: demaria.2{at}osu.edu.
Editor: D. L. Burns
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Baeuerle, P. A.
1998.
Pro-inflammatory signaling: last pieces in the NF- B puzzle?
Curr. Biol.
8:R19-R22[CrossRef][Medline].
|
| 2. | Ball, S. S., J. Prazma, C. G. D. Dais, R. J. Triana, and H. C. Pillsbury. 1997. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions. Ann. Otol. Rhinol. Laryngol. 106:633-639[Medline]. |
| 3. | Basolo, F., P. G. Conalde, L. Fiore, S. Calvo, and A. Toniolo. 1993. Normal breast epithelial cells produce interleukins 6 and 8 together with tumor necrosis factor: defective IL6 expression in mammary carcinoma. Int. J. Cancer 55:926-930[Medline]. |
| 4. |
Cario, E.,
I. M. Rosenberg,
S. L. Brandwein,
P. L. Beck,
H. C. Reinecker, and D. K. Podolsky.
2000.
Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors.
J. Immunol.
164:966-997 |
| 5. | Catanzaro, A., A. Ryan, S. Batcher, and S. I. Wasserman. 1991. The response to human rIL-1, rIL-2 and rTNF in the middle ear of guinea pigs. Laryngoscope 101:271-275[Medline]. |
| 6. | Cavaillon, J. M. 1999. Pathophysiological role of pro- and anti-inflammatory cytokines in sepsis. Sepsis 2:127-140. |
| 7. |
Clemans, D. L.,
R. J. Bauer,
J. A. Hanson,
M. V. Hobbs,
J. W. St. Geme III,
C. F. Marrs, and J. R. Gilsdorf.
2000.
Induction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae.
Infect. Immun.
68:4430-4440 |
| 8. | DeMaria, T. F., and D. M. Murwin. 1997. Tumor necrosis factor during experimental lipopolysaccharide-induced otitis media. Laryngoscope 107:369-372[CrossRef][Medline]. |
| 9. | DeMaria, T. F., M. A. Apicella, W. A. Nichols, and E. R. Leake. 1997. Evaluation of the virulence of nontypeable Haemophilus influenzae lipooligosaccharide htrB and rfaD mutants in the chinchilla model of otitis media. Infect. Immun. 65:4431-4435[Abstract]. |
| 10. |
DeMaria, T. F.,
R. B. Prior,
B. R. Briggs,
D. J. Lim, and H. G. Birck.
1984.
Endotoxin in middle ear effusions from patients with chronic otitis media with effusion.
J. Clin. Microbiol.
20:15-17 |
| 11. |
Fehniger, T. A.,
M. H. Shah,
M. J. Turner,
J. B. Van Deusen,
S. P. Whitman,
M. A. Cooper,
K. Suzuki,
M. Wechser,
F. Goodsaid, and M. A. Caligiuri.
1999.
Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
J. Immunol.
162:4511-4520 |
| 12. |
Gibson, U. E.,
C. A. Heid, and P. M. Williams.
1996.
A novel method for real time quantitative RT-PCR.
Genome Res.
6:995 |
| 13. |
Heid, C. A.,
J. Stevens,
K. J. Livak, and P. M. Williams.
1996.
Real time quantitative PCR.
Genome Res.
6:986 |
| 14. | Iino, Y., Y. Kaneko, and J. Takasaka. 1985. Endotoxin in middle ear effusions tested with Limulus assay. Acta Oto-Laryngol. 100:42-50[Medline]. |
| 15. | Ingalls, R. R., H. Heine, E. Lien, A. Yoshimura, and D. Golenbock. 1999. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. Infect. Dis. Clin. N. Am. 13:341-353[CrossRef][Medline]. |
| 16. |
Khair, O. A.,
J. L. Devalia,
M. M. Abdelaziz,
R. J. Sapsford,
H. Tarraf, and R. J. Davies.
1994.
Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF- and expression of ICAM-1 in cultured human bronchial epithelial cells.
Eur. Respir. J.
7:2109-2116[Abstract].
|
| 17. | Lee, N. G., M. G. Sunshine, and M. A. Apicella. 1995. Molecular cloning and characterization of the nontypeable Haemophilus influenzae 2019 rfaE gene required for lipopolysaccharide biosynthesis. Infect. Immun. 63:818-824[Abstract]. |
| 18. |
Lee, N. G.,
M. G. Sunshine,
J. J. Engstrom,
B. W. Gibson, and M. A. Apicella.
1995.
Mutation of the htrB locus of H. influenzae nontypeable strain 2019 is associated with modifications of lipid A and phosphorylation of the lipo-oligosaccharide.
J. Biol. Chem.
270:27151-27159 |
| 19. | Liu, Y. S., D. S. Lim, R. W. Lang, and H. G. Birck. 1975. Chronic middle ear effusions: immunochemical and bacteriological investigations. Arch. Otolaryngol. 101:278-286[Abstract]. |
| 20. | Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397[CrossRef][Medline]. |
| 21. |
Melhus, A., and A. F. Ryan.
2000.
Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat.
Infect. Immun.
68:4024-4031 |
| 22. | Morrison, D. C., and R. F. Ulevitch. 1978. The effects of bacterial endotoxin on host mediation systems. Am. J. Pathol. 93:527-617. |
| 23. | Mukaida, N., M. Shiroo, and K. Matsushima. 1989. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J. Immunol. 143:1366-1371[Abstract]. |
| 24. |
Nichols, W.,
C. R. Raetz,
T. Clementz,
A. L. Smith,
J. A. Hanson,
M. R. Ketterer,
M. Sunshine, and M. A. Apicella.
1997.
htrB of H. influenzae: determination of biochemical activity and effects on virulence and lipooligosaccharide toxicity.
J. Endotoxin Res.
4:163-172 |
| 25. | Nichols, W. A., B. W. Gibson, W. Melaugh, N.-G. Lee, M. Sunshine, and M. A. Apicella. 1997. Identification of the ADP-L-glycero-D-manno-heptose-6-epimerase (rfaD) and heptosyltransferase II (rfaF) biosynthesis genes from nontypeable Haemophilus influenzae 2019. Infect. Immun. 65:1377-1386[Abstract]. |
| 26. | Okazaki, N., T. F. DeMaria, B. R. Briggs, and D. J. Lim. 1984. Experimental otitis media with effusion induced by nonviable Hemophilus [sic] influenzae: cytologic and histologic study. Am. J. Otolaryngol. 5:80-92[Medline]. |
| 27. |
Patel, J.,
T. Chonmaitree, and F. Schmalsteig.
1993.
Effect of modulation of polymorphonuclear leukocyte migration with anti-CD18 antibody on pathogenesis of experimental otitis media in guinea pigs.
Infect. Immun.
61:1132-1135 |
| 28. |
Rock, F. L.,
G. Hardiman,
J. C. Timans,
R. A. Kastelein, and J. F. Bazan.
1998.
A family of human receptors structurally related to Drosophila Toll.
Proc. Natl. Acad. Sci. USA
95:588-593 |
| 29. |
Sato, K.,
C. L. Liebeler,
M. K. Quartey,
C. T. Le, and G. S. Giebink.
1999.
Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model.
Infect. Immun.
67:1943-1946 |
| 30. |
Sato, K.,
M. Kwana,
N. Nonomura, and Y. Nakano.
1999.
Course of IL-1 , IL-6, IL-8, and TNF- in the middle ear fluid of guinea pig otitis media model induced by nonviable H. influenzae.
Ann. Otol. Rhinol. Laryngol.
108:599-563[Medline].
|
| 31. | Shyy, Y.-J., Y.-S. Li, and P. E. Kolattukudy. 1990. Structure of human monocyte chemotactic protein gene and its regulation by TPA. Biochem. Biophys. Res. Commun. 169:346-351[CrossRef][Medline]. |
| 32. | Storgaard, M., K. Larsen, S. Blegvad, H. Nodgaard, T. Ovesen, P. L. Anderson, and N. Obet. 1997. Interleukin-8 and chemotactic activity of middle ear effusions. J. Infect. Dis. 175:474-477[Medline]. |
| 33. |
Tobias, P. S.,
K. Soldau,
J. A. Gregner,
D. Mintz, and R. J. Ulevitch.
1995.
Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14.
J. Biol. Chem.
270:10482-10488 |
| 34. |
van Furth, A. M.,
E. M. Verhard-Seijmonsbergen,
J. A. Langermans,
J. T. van Dissel, and R. van Furth.
1999.
Anti-CD14 monoclonal antibodies inhibit the production of tumor necrosis factor alpha and interleukin-10 by human monocytes stimulated with killed and live Haemophilus influenzae or Streptococcus pneumoniae organisms.
Infect. Immun.
67:3714-3718 |
| 35. |
Willet, D. N.,
R. P. Rezaee,
J. M. Billy,
M. B. Tighe, and T. F. DeMaria.
1998.
Relationship of endotoxin to tumor necrosis factor- and interleukin-1 in children with otitis media with effusion.
Ann. Otol. Rhinol. Laryngol.
7:28-33.
|
| 36. | Wright, S. D. 1991. Multiple receptors of endotoxin. Curr. Opin. Immunol. 3:83-90[CrossRef][Medline]. |
| 37. | Yamanaka, N., Y. Somekawa, T. Suzuki, and A. Kataura. 1987. Immunologic and cytologic studies in otitis media with effusions. Acta Otolaryngol. 104:481-486[Medline]. |
| 38. |
Zhang, F. X.,
C. J. Kirschning,
R. Mancinelli,
X. P. Xu,
Y. Jin,
E. Faure,
A. Mantovani,
M. Rothe,
M. Uzio, and M. Arditi.
1999.
Bacterial lipopolysaccharide activates nuclear factor B through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.
J. Biol. Chem.
274:7611-7614 |
| 39. | Zisman, D. A., S. L. Kunkel, R. M. Strieter, W. C. Tsai, K. Bucknell, J. Wilkowski, and T. J. Standiford. 1997. MCP-1 protects mice in lethal endotoxemia. J. Clin. Investig. 99:2832-2836[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|